Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Serum tobramycin levels after nebulised TOBI via e-flow in children with cystic fibrosis
2007-005346-20Phase 4Completed
- Sponsor
- Leeds Teaching Hospitals NHS Trust
- Start
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tobramycin in cystic fibrosis (CF), sponsored by Leeds Teaching Hospitals NHS Trust. Primary endpoint: Peak serum tobramycin concentration at 1 hour. Started Nov 2007; status: completed.
02
Drugs
tobramycin
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on 2007-005346-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005346-20.